Marco Infante received his M.D. degree at Sapienza University of Rome in 2014. Since 2015, Dr. Infante has been working at the Department of Systems Medicine of the University of Rome Tor Vergata, where he took part in the Endocrinology, Diabetes and Metabolic Disorders fellowship program. During his fellowship, Dr. Infante was involved in clinical activities at the Division of Endocrinology and Metabolic Disorders & Diabetic Foot Unit of Policlinico Tor Vergata, and at the Endocrinology and Diabetes Outpatient Clinic of CTO A. Alesini & S.Eugenio Hospital (Department of Systems Medicine of the University of Rome Tor Vergata). In 2019, Dr. Infante received the Board Certification in Endocrinology and Metabolic Disorders at University of Rome Tor Vergata. Dr. Infante is also a diagnostic medical sonographer specialized in the ultrasound of the Endocrine Neck. He received the Diploma in Clinical Ultrasound and the Advanced Diploma in Ultrasound in Endocrinology, which have been issued by the Italian Society for Ultrasound in Medicine and Biology (SIUMB) in 2016 and 2018, respectively.

Starting from January 2019, Dr. Infante has been serving as a Research Scholar at Diabetes Research Institute (DRI) of the University of Miami Miller School of Medicine (Miami, FL, USA), where he has been involved in clinical research in the field of type 1 diabetes, pancreatic islet transplantation, diabetes technology and immunotherapies for treatment of type 1 diabetes. Also, he has been participating in the Collaborative Islet Transplant Registry (CITR), an international registry aimed to expedite progress and promote safety in pancreatic islet transplantation through the collection, analysis, and communication of comprehensive and current data on all islet transplants performed in North America, as well as some European, Australian and Asian centers.

Dr. Infante is a member of several national and international scientific organizations and societies, including the American Diabetes Association (ADA), the International Pancreas and Islet Transplant Association (IPITA), the Italian Society of Endocrinology (SIE), the Italian Society of Diabetology (SID), and the Diabetes Research Institute Federation (DRIF, Rome Chapter, University of Rome Tor Vergata), a global alliance of researchers who are focused on the cure research for type 1 diabetes.

Starting from January 2020, Dr. Infante has been serving as the Managing Editor for CellR4, the official journal of “The Cure Alliance” (Editor-in-Chief: Prof. Camillo Ricordi). Moreover, Dr. Infante is currently serving on the Editorial board of Frontiers in Endocrinology, Frontiers in Public Health (specialty sections “Clinical Diabetes” and “Obesity”), Frontiers in Immunology (specialty section “Autoimmune and Autoinflammatory Disorders”) and World Journal of Clinical Cases. He also serves as an ad hoc reviewer for several international peer-reviewed journals: BMJ Open, Frontiers in Endocrinology, Frontiers in Immunology, Frontiers in Public Health, International Journal of Molecular Sciences, Journal of Clinical Medicine, Nutrients, Healthcare, Biomarkers in Medicine, among others. Dr. Infante authored several publications in national and international peer-reviewed journals and contributed to several invited book chapters and editorials. He gave lectures at national and international meetings, and participated in several national and international training courses, expert meetings, conferences and conventions as a speaker or faculty member.

In May 2020, Dr. Infante has been appointed Supervisor for the international Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA) of the Universal Scientific Education and Research Network (USERN).

Starting from July 2020, Dr. Infante has been holding the position of Adjunct Professor of Endocrinology at UniCamillus, Saint Camillus International University of Health Sciences (Rome, Italy).

To date, Dr. Infante is taking part into a PhD Program in Systems and Experimental Medicine at University of Rome Tor Vergata, where he has been carrying out clinical and research activities in the field of Endocrinology, Diabetes and Metabolic Disorders.